Session # P-032
Presenting Author: Kevin Beezhold, PhD
Take home points:
- In response to internal and external concerns about phenotype in heterozygous MSH3 pathogenic variant carriers, we reviewed our large internal cohort for any cancer predisposition.
- Our study expands on previous reports and understanding that there is no risk for common cancers in heterozygous carriers.
- Authors: Kevin Beezhold; Cassidy Carraway; Jennifer Herrera Mullar
- Conference:
CGA-IGC 2025
- Date: Friday, Oct 10, 2025 5:00pm - 6:00pm